United States · Series A startup

Who invested in OXOS Medical

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$34Mraised across 2 rounds since 2023, from 2 sources

$23MSeries A$11MRound
Latest round
Round, $11MDec 2025
Biggest round
$23MSeries A · Apr 2023
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20242025
$23MSeries A$11MRound
First round
Series A, $23M
Apr 2023
Biggest round
$23M
Series A · Apr 2023
Between rounds
2.7 years
from the last two

The rounds

  1. Dec 2025
    Round$11M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $11M sold, first sale Dec 2025

  2. Apr 2023
    Series A$23M1 new

    Source recordedSEC filing: $8.2M sold, first sale Feb 2022

Everyone who backed them

Intel CapitalCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about OXOS Medical

Who invested in OXOS Medical?

OXOS Medical's investors include Intel Capital.

How much has OXOS Medical raised?

OXOS Medical has raised $34M across 2 rounds since 2023.

When did OXOS Medical last raise?

OXOS Medical's most recent round, $11M, was in Dec 2025.

What was OXOS Medical's biggest round?

OXOS Medical's largest round on record is $23M (Series A), in Apr 2023.

Who backed OXOS Medical first?

OXOS Medical's first round on record, in Apr 2023, was backed by Intel Capital.

What stage is OXOS Medical at?

OXOS Medical's latest named round is a Series A, in Apr 2023.

Where is OXOS Medical based?

OXOS Medical is based in the United States.

Companies like OXOS Medical

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.